AAI Vanguard Award and Lecture

This award recognizes AAI member investigators who are underrepresented scientists noted for research achievement and exemplary career success. Click here for more information on this award.

Note: lecturers' institutional affiliations reflect their affiliations at the time of their award.

Year Recipient/Organization Lecture Title Sort Name
2023 Robert J. Binder, Ph.D. (AAI ’02)
Univ. of Pittsburgh
Key pathways in immunosurveillance of cancer Binder
2022 Cherié L. Butts, Ph.D.
Biogen
Concept to approved drug: why immunologists are critical when developing new medicines Butts
2020 De’Broski R. Herbert, Ph.D.
Univ. of Pennsylvania Sch. of Vet. Med.
IL-33 regulates the balance between inflammation and immunosuppression Herbert
2019 Margaret S. Bynoe, Ph.D.
Cornell University College of Veterinary Medicine
Adenosine receptor axis in blood brain barrier (BBB) permeability regulation Bynoe
2018 Elina Zúñiga, Ph.D.
University of California, San Diego
The art of coexistence: immune adaptations during chronic viral infections Zúñiga
2017 Tyler J. Curiel, M.D., M.P.H.
The University of Texas Health Science Center at San Antonio
Advancing towards optimized cancer immunotherapy Curiel
2016 Prosper N. Boyaka, Ph.D.
Ohio State University
Diversity: Lessons from regulation of mucosal immunity by toxins and microbiota Boyaka
2015 Gabriel Núñez, M.D.
University of Michigan
Linking pathogen virulence, immunity, and the microbiota Núñez
2014 Arturo Casadevall, Ph.D.
Albert Einstein College of Medicine, Yeshiva University
A new synthesis for antibody-mediated immunity Casadevall
2013 Esteban Celis, Ph.D.
Moffitt Cancer Center, University of South Florida
The long road to effective peptide vaccines for cancer: learning from infectious diseases and autoimmunity Celis
2012 Charles E. Egwuagu, M.P.H., Ph.D.
National Eye Institute, National Institutes of Health
Regulation of autoreactive lymphocytes that mediate CNS autoimmune diseases Egwuagu
2011 Olivia M. Martinez, Ph.D.
Stanford School of Medicine
Effects of viral proteins on lymphocyte function in Epstein Barr Virus B cell lymphomas Martinez
2010 Albert Zlotnik, Ph.D.
University of California, Irvine
An evolutionary view of chemokines Zlotnik
2009 Emil R. Unanue, M.D.
Washington University School of Medicine
The mysteries of peptide selection by the class II MHC molecules Unanue
2008 Juan J. Lafaille, Ph.D.
New York University School of Medicine
Antigen-induced Foxp3+ regulatory T cells Lafaille
2007 Avery August, Ph.D.
Pennsylvania State University
Tec tyrosine kinase modulation of airway responses August
2006 Diana M. Lopez, Ph.D.
University of Miami
A unique mucin immunoenhancing peptide with anti-tumor properties Lopez
2005 Juan Carlos Zúñiga-Pflücker, Ph.D.
Sunnybrook and Women’s Research Institute, University of Toronto
Becoming a T cell: lineage options and decisions by stem cells Zúñiga-Pflücker
2004 Randy R. Brutkiewicz, Ph.D.
Indiana University School of Medicine
CD1d-mediated antigen presentation to NKT Cells Brutkiewicz
2003 Richard A. Goldsby, Ph.D.
Amherst College
Human antibody from human artificial chromosome transgenic cloned cattle Goldsby

© The American Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650, Rockville, Maryland 20852
(301) 634-7178 | infoaai@aai.org